Surgery that preserves the lung, when combined with other therapies, appears to extend the lives of people with a subtype of the rare and deadly cancer mesothelioma, a new study suggests. Tracking 73 patients with advanced malignant pleural mesothelioma -- which affects the lungs' protective lining in the chest cavity -- researchers found that those treated with lung-sparing surgery had an average survival of nearly three years.